ECO Animal Health Group plc (FRA:LWA)

Market Cap	77.30M +18.7%
Revenue (ttm)	100.24M +10.0%
Net Income	2.51M +29.9%
EPS	0.04 +29.6%
Shares Out	n/a
PE Ratio	29.04
Forward PE	20.85
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,649
Open	1.070
Previous Close	1.090
Day's Range	1.070 - 1.090
52-Week Range	0.875 - 1.410
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers Ecomectin to treat parasites in cattle, sheep, and pigs; and ECOVAXXIN MS, a mycoplasma solution. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 213
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LWA

Financial Performance

In fiscal year 2026, ECO Animal Health Group's revenue was 87.53 million, an increase of 9.96% compared to the previous year's 79.60 million. Earnings were 2.19 million, an increase of 29.89%.

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error